The entire vision of the CREATIC is not only to deliver ambition research – we are going beyond – to deliver the results of the research to patients. Its mean the innovation strategy needs to contain as well as the new conceptual way of translating the results to clinical practise, including the new innovative models for reimbursement strategies.
The excellent research in biomedicine has to undergo extremely dangerous way - extreme price growth rates followed with problematic accessibility to new treatments and lack of proper reimbursement schemes. The sustainable fair pricing of the products is quite urgent and painful area, where CREATIC will be providing new scientific data and models in the area of health technology assessment and pharmaco-economics. CREATIC as well will focus on the IP law and the proper use of IP for benefit of the society.
By adopting and integrating the principles of Responsible Research and Innovation (RRI), the Centre of Excellence (CoE) will be able to offer patients and society a safe, unique, and financially sustainable treatment, hereinafter referred to as Fair Medicine.